GB9612063D0 - Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases - Google Patents

Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Info

Publication number
GB9612063D0
GB9612063D0 GBGB9612063.9A GB9612063A GB9612063D0 GB 9612063 D0 GB9612063 D0 GB 9612063D0 GB 9612063 A GB9612063 A GB 9612063A GB 9612063 D0 GB9612063 D0 GB 9612063D0
Authority
GB
United Kingdom
Prior art keywords
cyclooxygenase
compositions
once
mediated diseases
day treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9612063.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Merck and Co Inc
Original Assignee
Merck Frosst Canada and Co
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co, Merck and Co Inc filed Critical Merck Frosst Canada and Co
Priority to GBGB9612063.9A priority Critical patent/GB9612063D0/en
Publication of GB9612063D0 publication Critical patent/GB9612063D0/en
Priority to UA98126685A priority patent/UA51706C2/en
Priority to EA199801017A priority patent/EA001596B1/en
Priority to CA002254061A priority patent/CA2254061C/en
Priority to CZ19983738A priority patent/CZ291463B6/en
Priority to BR9709097A priority patent/BR9709097A/en
Priority to AU30049/97A priority patent/AU3004997A/en
Priority to SK1567-98A priority patent/SK284330B6/en
Priority to HU9902889A priority patent/HUP9902889A3/en
Priority to KR10-1998-0709239A priority patent/KR100373622B1/en
Priority to CNB971963150A priority patent/CN1140267C/en
Priority to PCT/US1997/008041 priority patent/WO1997044028A1/en
Priority to YU51698A priority patent/YU51698A/en
Priority to TR1998/02345T priority patent/TR199802345T2/en
Priority to US09/180,647 priority patent/US6063811A/en
Priority to IL12689997A priority patent/IL126899A/en
Priority to NZ332670A priority patent/NZ332670A/en
Priority to EE9800393A priority patent/EE03746B1/en
Priority to EP97924688A priority patent/EP0910368A1/en
Priority to JP9542486A priority patent/JPH11512754A/en
Priority to ARP970102021A priority patent/AR012014A1/en
Priority to DZ970087A priority patent/DZ2200A1/en
Priority to PE1997000379A priority patent/PE66998A1/en
Priority to HR9612063.9A priority patent/HRP970262A2/en
Priority to IDP971640A priority patent/ID16921A/en
Priority to CO97026568A priority patent/CO5050370A1/en
Priority to MYPI97002138A priority patent/MY116201A/en
Priority to IS4891A priority patent/IS4891A/en
Priority to NO985342A priority patent/NO985342L/en
Priority to BG103000A priority patent/BG103000A/en
Priority to PL97329940A priority patent/PL188649B1/en
Priority to HK00100645A priority patent/HK1021623A1/en
Pending legal-status Critical Current

Links

GBGB9612063.9A 1996-05-17 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases Pending GB9612063D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GBGB9612063.9A GB9612063D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
NZ332670A NZ332670A (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases comprising 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone
US09/180,647 US6063811A (en) 1996-05-17 1997-05-13 Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
YU51698A YU51698A (en) 1996-05-17 1997-05-13 Pharmaceutical composition for the treatment of cyclooxygenase-2 mediated diseases, said composition comprising a cyclooxygenase-2 inhibiting compound characterized by high potency, a long half-life and a high degree of specificity for inhibiting cyclooxygenase-2
CA002254061A CA2254061C (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
CZ19983738A CZ291463B6 (en) 1996-05-17 1997-05-13 Pharmaceutical composition
BR9709097A BR9709097A (en) 1996-05-17 1997-05-13 Pharmaceutical composition for the treatment of diseases mediated by cyclooxygenase process to treat an inflammatory disease susceptible to treatment with an anti-inflammatory agent in the steroid use and oral form of unit dose
AU30049/97A AU3004997A (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
EE9800393A EE03746B1 (en) 1996-05-17 1997-05-13 A pharmaceutical composition for the treatment of cyclooxygenase-2 mediated diseases, the use of 3-phenyl-4- (4- (methylsulfonyl) phenyl) -2- (5H) -furanone, and a unit oral dosage form
HU9902889A HUP9902889A3 (en) 1996-05-17 1997-05-13 The use of 3-phenyl-4-(4-methylsulphonyl)-phenyl-2-(5h)-furanone for producing anti inflammatory medicaments and such medicaments
KR10-1998-0709239A KR100373622B1 (en) 1996-05-17 1997-05-13 One-time therapeutic composition for diseases mediated with cyclooxygenase-2
CNB971963150A CN1140267C (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
PCT/US1997/008041 WO1997044028A1 (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
EA199801017A EA001596B1 (en) 1996-05-17 1997-05-13 Compositions for the treatment of cyclooxygenase-2 mediated diseases and method of treating an inflammatory disease
TR1998/02345T TR199802345T2 (en) 1996-05-17 1997-05-13 Compositions for once-daily administration in cyclooxygenase-2-mediated diseases.
UA98126685A UA51706C2 (en) 1996-05-17 1997-05-13 Method for treating inflammatory diseases by administering 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5h)-furanone
IL12689997A IL126899A (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
JP9542486A JPH11512754A (en) 1996-05-17 1997-05-13 Composition for once-daily treatment of cyclooxygenase-2-mediated disease
SK1567-98A SK284330B6 (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
EP97924688A EP0910368A1 (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
DZ970087A DZ2200A1 (en) 1996-05-17 1997-05-14 Compositions for once daily treatment of diseases mediated by 2-cyclooxygenase.
ARP970102021A AR012014A1 (en) 1996-05-17 1997-05-14 COMPOSITIONS FOR TREATMENT OF A DAY OF DISEASES MEDIATED BY CYCLOOXYGENASE-2
PE1997000379A PE66998A1 (en) 1996-05-17 1997-05-15 DAILY DOSE TREATMENT COMPOSITIONS FOR DISEASES PRODUCED BY CYCLOOXYGENASE-2
MYPI97002138A MY116201A (en) 1996-05-17 1997-05-16 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
HR9612063.9A HRP970262A2 (en) 1996-05-17 1997-05-16 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
IDP971640A ID16921A (en) 1996-05-17 1997-05-16 COMPOSITION FOR A DAY TREATMENT AGAINST DISEASES RELATED BY CYCLOXIGENASE-2
CO97026568A CO5050370A1 (en) 1996-05-17 1997-05-16 COMPOSITIONS FOR A TREATMENT OF DAILY SINGLE DOSE OF DISEASES MEDIATED BY CYCLOOXYGENASE -2
IS4891A IS4891A (en) 1996-05-17 1998-11-10 Compositions for once-daily treatment of cyclooxygenase-2-dependent diseases
NO985342A NO985342L (en) 1996-05-17 1998-11-16 Preparation for treatment Once per. day of cyclooxygenase-2-mediated diseases
BG103000A BG103000A (en) 1996-05-17 1998-12-08 Compositions for single daily dosage in the treatment of cyclooxygenase-2-dependent diseases
PL97329940A PL188649B1 (en) 1996-05-17 1999-01-11 Compositions for once-a-day administration for use in treating diseases involving mediator effect of cyclooxygenase-2
HK00100645A HK1021623A1 (en) 1996-05-17 2000-02-02 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612063.9A GB9612063D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Publications (1)

Publication Number Publication Date
GB9612063D0 true GB9612063D0 (en) 1996-08-14

Family

ID=10795017

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9612063.9A Pending GB9612063D0 (en) 1996-05-17 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Country Status (3)

Country Link
GB (1) GB9612063D0 (en)
UA (1) UA51706C2 (en)
YU (1) YU51698A (en)

Also Published As

Publication number Publication date
UA51706C2 (en) 2002-12-16
YU51698A (en) 2002-09-19

Similar Documents

Publication Publication Date Title
HRP970262A2 (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
IL129998A0 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU7250294A (en) Treatment of multidrug resistant diseases
GB9407135D0 (en) Treatment of osteoporosis
IL121170A0 (en) Compositions for the treatment of dermatological disorders
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU2935597A (en) Therapeutic treatment for vegf related diseases
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
AU2180097A (en) Composition for prevention and treatment of periodontal diseases
EP0938901A4 (en) Medicinal compositions for treating liver diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
AU4215499A (en) Treatment of neurodegenerative diseases
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
AU3122597A (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
GB9612063D0 (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
AU2754997A (en) The treatment of plant diseases
PL334103A1 (en) Novel therapeutic application of a derivative of thienylcyclohexylamine
EP0868430A4 (en) Therapeutic compositions
ZA974206B (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases.
GB9612065D0 (en) Compositions for a once a day treatment of cyclooxtgenase-2 mediated diseases
AU5854799A (en) Novel treatment of neurodegenerative diseases